Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

rAd-p53 Gene Therapy for Advanced Oral and Maxillofacial Malignant Tumors (rAd-p53)

The recruitment status of this study is unknown because the information has not been verified recently.
Verified February 2010 by Shenzhen SiBiono GeneTech Co.,Ltd.
Recruitment status was  Recruiting
Information provided by (Responsible Party):
Shenzhen SiBiono GeneTech Co.,Ltd Identifier:
First received: May 11, 2009
Last updated: April 6, 2012
Last verified: February 2010
No Study Results Posted on for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: July 2012
  Estimated Primary Completion Date: July 2012 (Final data collection date for primary outcome measure)